Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
University of Massachusetts Medical School
Worcester, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Massachusetts Medical School (10)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
Cancer Research Communications, Vol. 4, Núm. 7, pp. 1677-1689
2023
-
Long non-coding RNAs: definitions, functions, challenges and recommendations
Nature Reviews Molecular Cell Biology, Vol. 24, Núm. 6, pp. 430-447
2022
2021
-
Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease
Hepatology Communications, Vol. 5, Núm. 7, pp. 1165-1182
2020
-
Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury
Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 6, pp. 1300-1311
-
Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Hepatology Communications, Vol. 4, Núm. 6, pp. 834-851
-
RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation
Cellular and Molecular Gastroenterology and Hepatology, Vol. 9, Núm. 2, pp. 295-312
2017
-
IKBKE is required during KRAS-induced pancreatic tumorigenesis
Cancer Research, Vol. 77, Núm. 2, pp. 320-329